Suven Life Sciences Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Suven Life Sciences Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.40 billion Indian Rupees [US$82.99 million]
of which 96%
Morepen Laboratories Limited
(5.84 billion Indian Rupees [US$89.80 million]
of which 100%
was Pharmaceuticals), and
Neuland Laboratories Limited
(5.73 billion Indian Rupees [US$88.09 million]
Suven Life Sciences Limited reported sales of 5.44 billion Indian Rupees (US$83.60 million)
March of 2017.
increase of 8.8%
versus 2016, when the company's sales were 5.00 billion Indian Rupees.
Sales of Intermediaries Under Contract Research/m saw an increase
10.6% in 2017, from
4.67 billion Indian Rupees to 5.17 billion Indian Rupees.
Not all segments of Suven Life Sciences Limited experienced an increase in sales in 2017:
sales of Bulk Drugs/services fell 14.3% to 277.77 million Indian Rupees.